EUVIMEDEUVIMED entdecken
Open Access

A multimodal pipeline for the identification and diagnostic immunoPET validation of hepatocellular carcinoma targets for radiotheranostic development

Philip Homan, Joon-Yong Chung, Woonghee Lee, Divya Nambiar, Julia Sheehan-Klenk, Hima Makala, Stanley Fayn, Orit Jacobson, Arthur Paden King, Kyungeun Kim, Jeong Won Kim, Sung Ryol Lee und 5 weitere

Theranostics · 29.07.2026 · 16 (15) · 8501-8520

DOI: 10.7150/thno.136906 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Theranostics, erschienen am 29.07.2026. Verfasst von Philip Homan und 16 weiteren Autor:innen. Beteiligte Einrichtung: Advanced Biomedical Computational Science, Frederick National Laboratory for Cancer Research, Frederick, MD, 21702, USA. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Positron-Emission Tomography. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, Intramural NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsPositron-Emission TomographyAnimalsHumansMiceCell Line, TumorRadiopharmaceuticalsGlypicansTetraspaninsBiomarkers, TumorFemale

Stichwörter der Autor:innen

drug developmenthepatocellular carcinomaprecision oncologyradiopharmaceuticalsradiotheranostics

Substanzen

RadiopharmaceuticalsGlypicansTetraspaninsBiomarkers, Tumor

Autor:innen und Institutionen

  • Advanced Biomedical Computational Science, Frederick National Laboratory for Cancer Research, Frederick, MD, 21702, USA.
  • Molecular Imaging Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
  • Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford Ox3 7DQ, UK.
  • Department of Pathology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, 03181, Republic of Korea.
  • Department of Pathology, Kangnam Sacred Heart Hospital, Hallym University College of Medicine, Seoul, 07441, Republic of Korea.
  • Department of Surgery, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, 03181, Republic of Korea.

Förderung

  • NIH HHS
  • Intramural NIH HHS

Zitieren

APA

Homan, P., Chung, J. Y., Lee, W., Nambiar, D., Sheehan-Klenk, J., Makala, H., Fayn, S., Jacobson, O., King, A. P., Kim, K., Kim, J. W., Lee, S. R., Cam, M., Hewitt, S. M., Wang, X. W., Ho, M., & Escorcia, F. E. (2026). A multimodal pipeline for the identification and diagnostic immunoPET validation of hepatocellular carcinoma targets for radiotheranostic development. Theranostics, 16(15), 8501-8520. https://doi.org/10.7150/thno.136906

Vancouver

Homan P, Chung JY, Lee W, Nambiar D, Sheehan-Klenk J, Makala H, et al. A multimodal pipeline for the identification and diagnostic immunoPET validation of hepatocellular carcinoma targets for radiotheranostic development. Theranostics. 2026;16(15):8501-8520. doi:10.7150/thno.136906

BibTeX
@article{Homan2026,
  author = {Homan, Philip and Chung, Joon-Yong and Lee, Woonghee and Nambiar, Divya and Sheehan-Klenk, Julia and Makala, Hima and Fayn, Stanley and Jacobson, Orit and King, Arthur Paden and Kim, Kyungeun and Kim, Jeong Won and Lee, Sung Ryol and Cam, Maggie and Hewitt, Stephen M and Wang, Xin Wei and Ho, Mitchell and Escorcia, Freddy E},
  title = {A multimodal pipeline for the identification and diagnostic immunoPET validation of hepatocellular carcinoma targets for radiotheranostic development},
  journal = {Theranostics},
  year = {2026},
  volume = {16},
  number = {15},
  pages = {8501--8520},
  doi = {10.7150/thno.136906}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche